EIC Summit 25 Networking Platform

2–3 Apr 2025 | Brussels, Belgium

ServiceUpdated on 25 March 2025

EIC Access + Funded CRO Services

Ana Custódio

Co-CEO at VectorB2B

Lisboa, Portugal

About

This service can be EIC Acess + funded up to 60k. Apply here

This service offers a comprehensive suite of Contract Research Organization (CRO) solutions to support the entire drug development process, from early discovery to clinical trials. The service duration is tailored to the project's complexity and specific stages, typically ranging from a few months to over a year. It is aimed at pharmaceutical companies, biotech firms, and academic institutions involved in drug development and preclinical research. The goal of the service is to provide end-to-end project management and execution for preclinical and clinical studies, ensuring compliance with regulatory standards. Key activities include study design, data management, biomarker analysis, and regulatory submissions. These services are delivered by a team of in-house experts with deep industry experience, supported by state-of-the-art laboratory infrastructure.  Expected outcomes include high-quality data and reports ready for regulatory approval, enabling smooth transitions between research phases and ultimately accelerating the development pipeline. The service is customised to meet the needs of each client, ensuring efficiency and scientific rigor at every stage.

Type

  • Development

Organisation

VectorB2B

Incubators and Accelerators

Lisbon, Portugal

Similar opportunities

  • Service

    EIC ACCESS+ Funded GLP Tox Services

    • Development

    Ana Custódio

    Co-CEO at VectorB2B

    Lisboa, Portugal

  • Service

    EIC Access + Funded Discovery Services

    • Development

    Ana Custódio

    Co-CEO at VectorB2B

    Lisboa, Portugal

  • Investment

    Receive up to €60,000 in grant

    • Energy
    • Space
    • Others
    • Startup
    • Mobility
    • Expansion
    • AI, Data & ICT
    • Built Environment
    • Agriculture & Food
    • Medical Technologies
    • Speed and Development
    • Health Biotechnology
    • Climate & Environmental Tech
    • Advanced Manufacturing & Advanced Materials
    • Quantum, Advanced Computing & Semiconductors
    • Social Innovation, Culture & Creative Industries

    Alexander Romanishyn

    Board Member at ISE Group

    Kyiv / Warsaw, Poland